Anti-CREB3L2 monoclonal antibody

Pre-made anti-CREB3L2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CREB3L2/CREB3L2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0612-Ab-1/ GM-Tg-hg-IP0612-Ab-2Anti-Human CREB3L2 monoclonal antibodyHuman
GM-Tg-rg-IP0612-Ab-1/ GM-Tg-rg-IP0612-Ab-2Anti-Rat CREB3L2 monoclonal antibodyRat
GM-Tg-mg-IP0612-Ab-1/ GM-Tg-mg-IP0612-Ab-2Anti-Mouse CREB3L2 monoclonal antibodyMouse
GM-Tg-cynog-IP0612-Ab-1/ GM-Tg-cynog-IP0612-Ab-2Anti-Cynomolgus/ Rhesus macaque CREB3L2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0612-Ab-1/ GM-Tg-felg-IP0612-Ab-2Anti-Feline CREB3L2 monoclonal antibodyFeline
GM-Tg-cang-IP0612-Ab-1/ GM-Tg-cang-IP0612-Ab-2Anti-Canine CREB3L2 monoclonal antibodyCanine
GM-Tg-bovg-IP0612-Ab-1/ GM-Tg-bovg-IP0612-Ab-2Anti-Bovine CREB3L2 monoclonal antibodyBovine
GM-Tg-equg-IP0612-Ab-1/ GM-Tg-equg-IP0612-Ab-2Anti-Equine CREB3L2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0612-Ab-1/ GM-Tg-hg-IP0612-Ab-2; GM-Tg-rg-IP0612-Ab-1/ GM-Tg-rg-IP0612-Ab-2;
GM-Tg-mg-IP0612-Ab-1/ GM-Tg-mg-IP0612-Ab-2; GM-Tg-cynog-IP0612-Ab-1/ GM-Tg-cynog-IP0612-Ab-2;
GM-Tg-felg-IP0612-Ab-1/ GM-Tg-felg-IP0612-Ab-2; GM-Tg-cang-IP0612-Ab-1/ GM-Tg-cang-IP0612-Ab-2;
GM-Tg-bovg-IP0612-Ab-1/ GM-Tg-bovg-IP0612-Ab-2; GM-Tg-equg-IP0612-Ab-1/ GM-Tg-equg-IP0612-Ab-2
Products NameAnti-CREB3L2 monoclonal antibody
Formatmab
Target NameCREB3L2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CREB3L2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0612-Ag-1Recombinant multi-species CR3L2/ CREB3L2/ BBF2H7 protein


    Target information

    Target IDGM-IP0612
    Target NameCREB3L2
    Gene ID64764,208647,362339,714981,491369,101100293,785086,100064828
    Gene Symbol and SynonymsBBF2H7,C530025K05Rik,CREB3L2,Ra69,SCIRR69
    Uniprot AccessionQ70SY1,Q6QDP7
    Uniprot Entry NameCR3L2_HUMAN,CR3L2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182158
    Target ClassificationN/A

    The target: CREB3L2, gene name: CREB3L2, also named as BBF2H7. This gene encodes a member of the oasis bZIP transcription factor family. Members of this family can dimerize but form homodimers only. The encoded protein is a transcriptional activator. Translocations between this gene on chromosome 7 and the gene fused in sarcoma on chromosome 16 can be found in some tumors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.